key: cord-0813857-brvy5gpc authors: Simonetti, O.; Diotallevi, F.; Campanati, A.; Brisigotti, V.; Radi, G.; Molinelli, E.; Bobyr, I.; Martina, E.; Paolinelli, M.; Sapigni, C.; Offidani, A. title: Global Coronavirus Pandemic (SARS CoV‐2): Past, Present, And Future Of Pediatric Dermatology date: 2020-06-04 journal: Dermatol Ther DOI: 10.1111/dth.13767 sha: 0038194393153067ddd6eb7ee5a8d6b0e3ed28ab doc_id: 813857 cord_uid: brvy5gpc Two months have passed since the World Health Organization (WHO) declared the pandemic of the Coronavirus Disease 19 (COVID‐19), caused by the SARS CoV‐2 virus, on March 11, 2020. Medical and healthcare workers have continued to be on the frontline to defeat this disease, however, continual changes are being made to their working habits which are proving to be difficult. Although the skin is not the main target of the SARS CoV‐2 infection, it is strongly involved both directly and indirectly, in many aspects of dermatological disease management, and particularly in pediatric dermatology. In this manuscript, our goal was to provide a “up‐to‐date” account on this topic, through analysis of current literature and sharing our experiences during this pandemic. This article is protected by copyright. All rights reserved. Two months have passed since the World Health Organization (WHO) declared the pandemic of the Coronavirus Disease 19 , caused by the SARS CoV-2 virus, on March 11, 2020. Medical and healthcare workers have continued to be on the frontline to defeat this disease, however, continual changes are being made to their working habits which are proving to be difficult. Although the skin is not the main target of the SARS CoV-2 infection, it is strongly involved both directly and indirectly, in many aspects of dermatological disease management, and particularly in pediatric dermatology. In this manuscript, our goal was to provide a "up-to-date" account on this topic, through analysis of current literature and sharing our experiences during this pandemic. In particular, we analyzed the changes in dermatological organization and management as well as the clinical-dermatological management of pediatric patients. This article is protected by copyright. All rights reserved. As soon as the first cases of the COVID-19 contagion occurred in Italy, and even whilst occurring in China, it was determined that dermatology departments could be potentially at a high risk for COVID-19 outbreaks (3) . Therefore, several measures were taken to reduce the risk of contagion between patients and health professionals. On March 9, 2020, the President of the Italian Council of Ministers decreed the beginning of the "lockdown phase" in which substantially all commercial and productive activities were closed and movement of the population was banned, except for urgent reasons (4). On that date, health monitoring of the spread of the SARS CoV-2 in the Italian territory showed that 7985 people tested positive for the virus, 724 had recovered, 4316 people were hospitalized with symptoms (733 in intensive care units), 2936 people were isolated at home, and 463 had died (5) . As in every hospital in Italy, the United Hospital of Ancona City worked to deal with emergencies through the strengthening of emergency care activities and with a reduction of non-urgent services. In this scenario, pediatric dermatology also underwent an important reorganization with a substantial modulation of the services offered. This was done also to reflect the role that children play in the COVID-19 pandemic. Chinese reports dating back to February 2020 reported that the SARS-CoV-2 affected children and adolescents less frequently than adults (less than 1% prevalence in children under 10 years of age) and that the infections had a predominantly asymptomatic course (6) . Nonetheless, the latter fact did not translate into an impossibility of the transmission of the disease, which was present mainly in the family environment (7), thus making children "possible infectors". For this reason and considering that every pediatric patient is accompanied by at least one parent, in order to avoid grouping in hospitals, access for pediatric patients was prohibited except for urgent reasons. However, patients were not abandoned; a telephone and WhatsApp call center as well as an e-mail consulting service were immediately set up and managed by dermatology residents under the This article is protected by copyright. All rights reserved. supervision of an expert dermatologist tutor, through which patients and their parents could communicate with us. In a span of two months, approximately 140 contacts were made, with more than 50% of the requests relating to changes in therapies already in progress. The remaining patient requests involved the rescheduling of services (laser and cryotherapy) that had been previously booked (30%) and soliciting visits for acute illnesses (20%). (10) . These lesions appear to be related to vascular alteration, secondary to cell-mediated responses to initial viral infection; however, further studies are needed to confirm this (11) . In our clinic we observed two cases of chilblain-like lesions; in a 12-year-old teenager and in an 8-year-old boy, both with a relative who had tested positive for the SARS-CoV2 (11). The current epidemiological trend of the pandemic in Italy shows a significant reduction in contagions and in patients admitted to the intensive care unit. This has allowed the start of Phase two (12), which consists of maintaining social distancing but with a resumption of productive and commercial activities. In our hospital, Phase two also began with the partial reopening of some activities that had previously been completely shut down (Fig.1) . In our pediatric dermatology clinic, the following outpatient clinics have been reactivated: general dermatological consultation (10 visits per week) and pediatric medications and cryotherapy (5 visits per week), in addition to the urgent visits already This article is protected by copyright. All rights reserved. made previously. For each outpatient service, a specific clinical-assistance pathway has been traced to protect the health of both the patient and the operator. The telephone and e-mail counseling services have currently remained active with the additional task of carrying out a triage for patients who need to make an outpatient visit to assess a possible SARS-CoV2 infection. At present we do not know if there will be a new wave of pandemics in the coming months, so it is necessary to carefully respect the rules of social distancing, especially in hospitals. It is also essential to continue evaluating possible skin manifestations of the virus, especially in children, in order to identify those who could be pauci-symptomatic subjects, and have the potential to infect others. For the aforementioned reasons, it is necessary to increase teledermatology and teleconsulting services (13) , for both patients and pediatricians, and reserve hospital access only to those who really need it. Covid-19: WHO declares pandemic because of "alarming levels" of spread, severity, and inaction Global coronavirus pandemic (2019-nCOV): Implication for an Italian medium size dermatological clinic of a ii level hospital Emergency management for preventing and controlling nosocomial infection of 2019 novel coronavirus: implications for the dermatology department Further implementing measures of Legislative Decree No 6 of 23 February 2020 on emergency measures for the containment and management of the COVID-19 emergency Covid-19: i casi in Italia alle ore 18 del 9 marzo Clinical Characteristics of Coronavirus Disease 2019 in China Alert for non-respiratory symptoms of Coronavirus Disease 2019 (COVID-19) patients in epidemic period: A case report of familial cluster with three asymptomatic COVID-19 patients Active implications for dermatologists in "SARS-CoV-2 era": Personal experience and review of literature Cutaneous Signs in COVID-19 Patients: A Review Chilblains in children in the setting of COVID-19 pandemic Skin Involvement in SARS-CoV-2 Infection: Case Series Amendment of Annexes 1, 2 and 3 of the Prime Ministerial Decree of 26 Teledermatology: a useful tool to fight COVID-19 This article is protected by copyright. All rights reserved This article is protected by copyright. All rights reserved.